TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 116 filers reported holding TRICIDA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $254,000 | +7.2% | 54,758 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $237,000 | -18.3% | 54,758 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $290,000 | -90.9% | 54,758 | -87.9% | 0.00% | -89.7% |
Q4 2020 | $3,182,000 | -87.7% | 451,377 | -84.2% | 0.04% | -91.8% |
Q3 2020 | $25,897,000 | -55.5% | 2,858,415 | +34.9% | 0.48% | -55.8% |
Q2 2020 | $58,230,000 | +24.5% | 2,119,000 | -0.4% | 1.08% | -18.1% |
Q1 2020 | $46,785,000 | -41.8% | 2,126,600 | -0.1% | 1.31% | -31.7% |
Q4 2019 | $80,352,000 | +25.3% | 2,129,100 | +2.5% | 1.92% | -10.4% |
Q3 2019 | $64,139,000 | -16.4% | 2,077,700 | +6.8% | 2.15% | -1.2% |
Q2 2019 | $76,758,000 | +305.4% | 1,945,200 | +296.7% | 2.17% | +292.1% |
Q1 2019 | $18,935,000 | +63.0% | 490,300 | -0.5% | 0.55% | +18.6% |
Q4 2018 | $11,616,000 | -23.2% | 492,600 | -0.5% | 0.47% | +0.4% |
Q3 2018 | $15,122,000 | +1.2% | 495,000 | -1.0% | 0.46% | -8.5% |
Q2 2018 | $14,950,000 | – | 500,000 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |